PORTERFIELD, FETTIG & SEARS, LLC

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceuticals

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Illinois

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Health Issues

General issues related to drug research and innovation; issues related to the Congressional Plasma Caucus.

Taxation/Internal Revenue Code

Issues related to global taxes, specifically Section 899 of H.R. 1.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.